Price
No data yet.
Social Signal Score
Analyst Ratings
22 analystsRevenue
$848.90M+193.05%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- J. Eric Evans
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Employees
- 16,000
- Beta
- 1.92
- Country
- US
- Piotroski score
- 4 / 9 (Middling)
- Altman Z-score
- 0.89
Financials
Revenue
$848.90M+193.0%Net Income
$-15.00M-807.5%EBITDA
$141.40M+133.1%Free Cash Flow
$37.50M+247.3%EPS (diluted)
$-0.12-400.0%Shares Outstanding (diluted)
128.82M+167.7%Operating Expenses
$36.30MCash & Debt
$216.70MReturn of Capital
$0.00Revenue by Segment (annual)
$6.54BQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $3.31B | $-77.90M | $-0.61 |
| 2024 | $3.11B | $-168.10M | $-1.33 |
| 2023 | $2.74B | $-11.90M | $-0.09 |
| 2022 | $2.54B | $-54.60M | $-0.59 |
| 2021 | $2.23B | $-70.90M | $-1.12 |
| 2020 | $1.86B | $-116.10M | $-3.19 |
| 2019 | $1.83B | $-74.80M | $-2.29 |
| 2018 | $1.77B | $-205.71M | $-4.28 |
| 2017 | $1.34B | $-52.98M | $-1.09 |
| 2016 | $1.15B | $9.45M | $0.20 |
| 2015 | $959.89M | $1.43M | $0.04 |
| 2014 | $403.29M | $-65.90M | $-1.37 |
| 2013 | $284.60M | $-9.06M | $-0.19 |
| 2012 | $260.21M | $1.92M | $0.04 |
Valuation
SGRYhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
50-70.59%Social Signal Score
Mentions (3)
- Newszacks.com·13d ago·Neutral
Surgery Partners (SGRY) Soars 15.7%: Is Further Upside Left in the Stock? Surgery Partners (SGRY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
View source ↗ - Newsseekingalpha.com·56d ago·Positive
Surgery Partners, Inc. (SGRY) Q2 2026 Earnings Call Transcript Surgery Partners, Inc. (SGRY) Q2 2026 Earnings Call Transcript
View source ↗ - Newszacks.com·57d ago·Positive
Surgery Partners (SGRY) Q2 Earnings and Revenues Beat Estimates Surgery Partners (SGRY) came out with quarterly earnings of $0.1 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to earnings of $0.17 per share a year ago.
View source ↗
Earnings
Mon, Nov 9(in 5 weeks)
Consensus estimate $0.09 per share
Typical surprise +6.3% (median, so one quarter with a near-zero estimate can't distort it)
- Mon, Aug 10$0.10 vs $0.06beat
- Tue, May 5$-0.03 vs $-0.15beat
- Mon, Mar 2$0.12 vs $0.31miss
- Mon, Nov 10$0.13 vs $0.19miss
- Tue, Aug 5$0.17 vs $0.16beat
- Mon, May 12$0.04 vs $0.08miss
Estimates and results for SGRY via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by SGRY officers and directors.
- Bought
- $305k
- Sold
- $7.4m
2 trades
35 trades
- Deluca Teresabought
- Deluca Teresabought
- Doherty David Tsold
- Evans Jason Ericsold
- Burkhalter Daniellesold
- Brittenham Marissasold
- Baldock Jennifersold
- Evans Jason Ericsold
62 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in SGRY.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.